Ceftazidime

CAS 72558-82-8 7 current records 3 historicalSmall Molecule

Who holds supplier records for Ceftazidime? 7 organisations hold a current record for Ceftazidime: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Italy (2), India (1), China (1), South Korea (1) and 1 other country (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Ceftazidime: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/ceftazidime

Reading the evidence

  • 7 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (7)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Ceftazidime. Country is the organisation's recorded country, not necessarily the manufacturing site.

Italy2India1China1South Korea1Austria1Country not recorded for 1
  • ACS DOBFAR SPA
    Active DMF 17628 · latest filing Aug 2004
    ItalyCEP Company GMP cert on record
  • FRESENIUS KABI IPSUM SRL
    Active DMF 38741 · latest filing Dec 2023
    ItalyCEP Company GMP cert on record
  • Orchid Pharma Limited
    Active DMF 23294 · latest filing Dec 2009
    IndiaCEP Company GMP cert on record
  • GLAXOSMITHKLINE LLC
    Active DMF 24339 · latest filing Mar 2011
  • Qilu Antibiotics Pharmaceutical Co., Ltd.
    ChinaCEP Company GMP cert on record
  • HANMI FINE CHEMICAL CO., LTD.
    Valid CEP holder (EDQM); not necessarily the manufacturer
    South KoreaCEP
  • SANDOZ GMBH
    Valid CEP holder (EDQM); not necessarily the manufacturer
    AustriaCEP
Need Ceftazidime sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (6)

Certificates of Suitability on the EDQM register for Ceftazidime, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 10 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ACS DOBFAR S.P.A. TribianoIT
CEP 2023-299 - Rev 01
Ceftazidime Pentahydrate, Sterile
Jun 2026—
ORCHID PHARMA LIMITED AlathurIN
CEP 2005-028 - Rev 05
Ceftazidime Pentahydrate, Sterile
Sept 2024Inspected Oct 2024
Poland
HANMI FINE CHEMICAL CO., LTD. Siheung-siKR
R1-CEP 2002-069 - Rev 07
Ceftazidime Pentahydrate, Sterile
Jun 2023—
FRESENIUS KABI IPSUM S.R.L. Cassina de’ PecchiIT
R1-CEP 2004-129 - Rev 07
Ceftazidime Pentahydrate, Sterile
May 2023—
Qilu Antibiotics Pharmaceutical Co., Ltd. JinanCN
R1-CEP 2016-195 - Rev 00
Ceftazidime Pentahydrate, Sterile
Nov 2022—
SANDOZ GMBH KundlAT
R1-CEP 2001-252 - Rev 04
Ceftazidime Pentahydrate, Sterile
Jun 2015—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (3)

Organisations whose Type II DMFs for Ceftazidime are no longer active. These show a past filing, not current supply.

Show all 3 historical records
  • Kyongbo Pharmaceutical Co., Ltd.
    South · Inactive DMF 25710 · filed Dec 2011
  • India · Inactive DMF 19644 · filed Jul 2006
  • GLAXO WELLCOME INC
    Inactive DMF 13650 · filed Aug 2000

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Ceftazidime is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL44354).

Chemical identity

IUPAC name
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Canonical SMILES
CC(C)(C(=O)O)O/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]
InChIKey
ORFOPKXBNMVMKC-DWVKKRMSSA-N
Synonyms
Ceftazidima, Ceftazidime, Ceftazidime anhydrous, Ceftazidime (arginine formulation), Ceftazidime component of avycaz, Ceftazidime component of zavicefta, Ceftazidime hydrate, Ceftazidime pentahydrate, Ceptaz, Fortam, Fortaz, Fortum

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Cephalosporin Antibacterial
Chemical structure
Cephalosporins

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Ceftazidime?

7 organisations hold an active US FDA Type II Drug Master File or a CEP for Ceftazidime: ACS DOBFAR SPA (Italy), FRESENIUS KABI IPSUM SRL (Italy), Orchid Pharma Limited (India), GLAXOSMITHKLINE LLC, Qilu Antibiotics Pharmaceutical Co., Ltd. (China), HANMI FINE CHEMICAL CO., LTD. (South Korea) and SANDOZ GMBH (Austria). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Ceftazidime Drug Master Files are active?

ACS DOBFAR SPA (DMF 17628), FRESENIUS KABI IPSUM SRL (DMF 38741), Orchid Pharma Limited (DMF 23294) and GLAXOSMITHKLINE LLC (DMF 24339). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Ceftazidime records mean?

3 organisations have only inactive Type II DMFs for Ceftazidime. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Ceftazidime have a European Certificate of Suitability?

Yes. 6 organisations hold a valid CEP for Ceftazidime on the EDQM register, including ACS DOBFAR S.P.A. Tribiano (IT), ORCHID PHARMA LIMITED Alathur (IN), HANMI FINE CHEMICAL CO., LTD. Siheung-si (KR), FRESENIUS KABI IPSUM S.R.L. Cassina de’ Pecchi (IT), Qilu Antibiotics Pharmaceutical Co., Ltd. Jinan (CN) and SANDOZ GMBH Kundl (AT). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Ceftazidime supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Ceftazidime?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.